TY - JOUR T1 - Are we ready for COVID-19’s Golden Passport? Insights from a Global Physician Survey JF - medRxiv DO - 10.1101/2020.11.25.20234195 SP - 2020.11.25.20234195 AU - P. Murali Doraiswamy AU - Mohan Chilukuri AU - Alexandra R. Linares AU - Katrina A. Bramstedt Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/19/2020.11.25.20234195.abstract N2 - Introduction COVID-19 immunity passports could protect the right to free movement, but may also critics worry about insufficient evidence, privacy, fraud, and discrimination. We aimed to characterize the global physician community’s opinion regarding immunity passports.Methods Cross sectional, random stratified sample of physicians registered with Sermo, a global networking platform open to verified and licensed physicians. The survey aimed to sample 1,000 physicians divided among the USA, EU and rest of the world. The survey question on immunology asked physicians to offer their insights into whether we know enough about COVID-19 immunity and its duration to offer immunity passports at the present time.Results The survey was completed by 1004 physicians (67 specialties, 40 countries, 49% frontline specialties) with a mean (SD) age of 49.14 (12) years. Overall, 52% answered NO, 17% were UNCERTAIN, and 31% answered YES (P <0.05). EU physicians were more likely to sayYES but even among them it did not exceed 35% approval. US physicians (60%) were more likely to say NO.Conclusion Our findings suggest a current lack of support among physicians for immunity passports. It is hoped that ongoing research and vaccine trials will provide further clarity.Competing Interest StatementPMD has received research grants from and/or served as an advisor or board member to government agencies, technology and healthcare businesses, and advocacy groups for other projects, and owns shares in companies whose products are not discussed here. Professor Bramstedt owns a bioethics consulting company (AskTheEthicist, LLC) with industry clients involved in immunology and COVID-19; however, none of her clients were involved in this project.Funding StatementThe authors received no external funding support for these analyses and have no financial ties to Sermo. Sermo provided the platform but was not involved in data interpretation, manuscript preparation, or decision to submit. Authors had full access to all the data and accept responsibility to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This anonymous survey was conducted in September 2020 following an online informed consent process. This was a broad survey across many topics of which one question pertained to immunology. De-identified data was analyzed for this report. This was reviewed and deemed exempt research by the Duke University Medical Center Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon approval for publication in a peer reviewed journal. ER -